Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: HLF USNA NATR MED HELE PG CL EL KMB CHD

| Held by: VXF IWC DFAC DCOR

Index	-	P/E	-	EPS (ttm)	-0.08	Insider Own	35.10%	Shs Outstand	11.51M	Perf Week	-2.35%
Market Cap	43.06M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	7.47M	Perf Month	2.19%
Enterprise Value	16.19M	PEG	-	EPS next Q	-	Inst Own	10.58%	Short Float	0.63%	Perf Quarter	3.60%
Income	-0.88M	P/S	1.08	EPS this Y	-	Inst Trans	-20.03%	Short Ratio	1.01	Perf Half Y	-14.22%
Sales	39.78M	P/B	1.65	EPS next Y	-	ROA	-1.88%	Short Interest	0.05M	Perf YTD	21.04%
Book/sh	2.27	P/C	1.49	EPS next 5Y	-	ROE	-3.13%	52W High	6.00 -37.67%	Perf Year	-27.66%
Cash/sh	2.51	P/FCF	-	EPS past 3/5Y	- -	ROIC	-3.59%	52W Low	2.40 55.83%	Perf 3Y	-38.48%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-6.80% -8.52%	Gross Margin	73.54%	Volatility	4.06% 4.78%	Perf 5Y	-50.92%
Dividend TTM	0.80 (21.39%)	EV/Sales	0.41	EPS Y/Y TTM	-253.51%	Oper. Margin	-4.55%	ATR (14)	0.19	Perf 10Y	-81.54%
Dividend Ex-Date	Feb 17, 2026	Quick Ratio	2.35	Sales Y/Y TTM	-7.42%	Profit Margin	-2.22%	RSI (14)	52.65	Recom	-
Dividend Gr. 3/5Y	0.00% 0.00%	Current Ratio	2.50	EPS Q/Q	-433.99%	SMA20	-0.95%	Beta	0.78	Target Price	-
Payout	1606.43%	Debt/Eq	0.09	Sales Q/Q	-10.11%	SMA50	8.94%	Rel Volume	0.73	Prev Close	3.75
Employees	133	LT Debt/Eq	0.05	Earnings	Feb 04 BMO	SMA200	-9.90%	Avg Volume	46.91K	Price	3.74
IPO	Jun 22, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	- -	Trades		Volume	34,238	Change	-0.27%

Feb-11-26 11:09AM	Natural Health Stock Gains Post Q4 Earnings, Gross Margin Slips (Zacks)
Feb-05-26 08:01PM	Natural Health Trends Corp (NHTC) Q4 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com) -7.50%
Feb-04-26 09:10AM	Natural Health Trends: Q4 Earnings Snapshot (Associated Press Finance) +6.67%
09:00AM	Natural Health Trends Reports Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Jan-28-26 09:00AM	Natural Health Trends to Report Fourth Quarter and Full Year 2025 Financial Results on February 4th (GlobeNewswire)
12:20PM	Loading…
Nov-10-25 12:20PM	Natural Health Stock Down Following Mixed Q3 Earnings & Restructuring (Zacks)
Nov-07-25 06:00AM	Natural Health Trends Corp (NHTC) Q3 2025 Earnings Call Highlights: Strategic Restructuring ... (GuruFocus.com) +30.16%
Nov-05-25 09:06AM	Natural Health Trends: Q3 Earnings Snapshot (Associated Press Finance) -23.29%
09:00AM	Natural Health Trends Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Oct-29-25 05:15PM	Natural Health Trends to Report Third Quarter 2025 Financial Results on November 5th (GlobeNewswire)
Aug-08-25 05:18AM	The Zacks Analyst Blog Highlights NVIDIA, Palantir, Coca-Cola, Kewaunee Scientific and Natural Health Trends (Zacks)
Aug-07-25 04:44PM	Top Research Reports for NVIDIA, Palantir & Coca-Cola (Zacks)
Aug-04-25 12:31PM	NHTC Stock Gains Despite Decline in Q2 Earnings, Gross Margin Down (Zacks)
Jul-31-25 03:27AM	Natural Health Trends Corp (NHTC) Q2 2025 Earnings Call Highlights: Strategic Moves Amidst ... (GuruFocus.com)
Jul-30-25 09:00AM	Natural Health Trends Reports Second Quarter 2025 Financial Results (GlobeNewswire)
09:00AM	Loading…
Jul-23-25 09:00AM	Natural Health Trends to Report Second Quarter 2025 Financial Results on July 30th (GlobeNewswire)
May-27-25 10:02AM	The Zacks Analyst Blog Highlights Costco Wholesale, Chubb, Cigna, Global Self Storage and Natural Health Trends (Zacks)
May-23-25 05:00PM	Top Research Reports for Costco, Chubb & Cigna (Zacks)
May-05-25 12:11PM	NHTC Stock Gains After Q1 Earnings, Operating Loss Narrows (Zacks)
May-01-25 03:17AM	Q1 2025 Natural Health Trends Corp Earnings Call (Thomson Reuters StreetEvents)
03:16AM	Natural Health Trends Corp (NHTC) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
Apr-30-25 03:04PM	Natural Health Trends Corp (NHTC) Q1 2025 Earnings Call Transcript (Seeking Alpha)
09:09AM	Natural Health Trends: Q1 Earnings Snapshot (Associated Press Finance)
09:00AM	Natural Health Trends Reports First Quarter 2025 Financial Results (GlobeNewswire)
Apr-23-25 09:00AM	Natural Health Trends to Report First Quarter 2025 Financial Results on April 30th (GlobeNewswire)
Mar-20-25 05:00AM	The Zacks Analyst Blog Highlights Shell, Uber, TotalEnergies, Geospace and Natural Health Trends (Zacks)
Mar-19-25 06:31PM	Top Analyst Reports for Shell, Uber & TotalEnergies (Zacks)
Feb-06-25 04:33AM	Q4 2024 Natural Health Trends Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-05-25 09:14AM	Natural Health Trends: Q4 Earnings Snapshot (Associated Press Finance)
09:00AM	Natural Health Trends Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
09:00AM	Loading…
Jan-29-25 09:00AM	Natural Health Trends to Report Fourth Quarter 2024 Financial Results on February 5th (GlobeNewswire)
Oct-31-24 03:42AM	Q3 2024 Natural Health Trends Corp Earnings Call (Thomson Reuters StreetEvents)
03:14AM	Natural Health Trends Corp (NHTC) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ... (GuruFocus.com)
Oct-30-24 09:00AM	Natural Health Trends Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-23-24 09:00AM	Natural Health Trends to Report Third Quarter 2024 Financial Results on October 30th (GlobeNewswire)
Aug-01-24 12:50PM	Natural Health (NHTC) Q2 Earnings Improve Y/Y, Gross Margin Up (Zacks)
07:35AM	Q2 2024 Natural Health Trends Corp Earnings Call (Thomson Reuters StreetEvents)
Jul-31-24 09:05AM	Natural Health Trends: Q2 Earnings Snapshot (Associated Press Finance)
09:00AM	Natural Health Trends Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-24-24 09:00AM	Natural Health Trends to Report Second Quarter 2024 Financial Results on July 31st (GlobeNewswire)
May-02-24 12:31PM	Natural Health Trends Corp. (NASDAQ:NHTC) Q1 2024 Earnings Call Transcript (Insider Monkey)
01:04AM	Q1 2024 Natural Health Trends Corp Earnings Call (Thomson Reuters StreetEvents)
May-01-24 01:53PM	NHTC Stock Earnings: Natural Health Trends Reported Results for Q1 2024 (InvestorPlace)
09:05AM	Natural Health Trends: Q1 Earnings Snapshot (Associated Press Finance)
09:00AM	Natural Health Trends Reports First Quarter 2024 Financial Results (GlobeNewswire)
Apr-24-24 09:00AM	Natural Health Trends to Report First Quarter 2024 Financial Results on May 1st (GlobeNewswire)
Apr-16-24 02:52AM	12 Highest Yielding Dividend Stocks You Can Buy Right Now (Insider Monkey)
Mar-17-24 08:38AM	15 Highest Quality Probiotics For Gut Health (Insider Monkey)
Feb-08-24 09:03AM	Natural Health Trends Corp. (NASDAQ:NHTC) Q4 2023 Earnings Call Transcript (Insider Monkey)
01:03AM	Q4 2023 Natural Health Trends Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-07-24 09:17AM	Natural Health Trends: Q4 Earnings Snapshot (Associated Press Finance)
09:00AM	Natural Health Trends Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Jan-31-24 09:00AM	Natural Health Trends to Report Fourth Quarter 2023 Financial Results on February 7th (GlobeNewswire)
Nov-16-23 12:18PM	12 Best Debt Free Stocks To Buy (Insider Monkey)
Nov-02-23 10:16AM	Natural Health Trends Corp. (NASDAQ:NHTC) Q3 2023 Earnings Call Transcript (Insider Monkey)
12:42AM	Q3 2023 Natural Health Trends Corp Earnings Call (Thomson Reuters StreetEvents)
Nov-01-23 10:32AM	Natural Health Trends Corp (NHTC) Reports Q3 2023 Earnings: Cash Flows Improve by $1.4 Million (GuruFocus.com)
09:12AM	Natural Health Trends: Q3 Earnings Snapshot (Associated Press Finance)
09:00AM	Natural Health Trends Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-25-23 09:00AM	Natural Health Trends to Report Third Quarter 2023 Financial Results on November 1st (GlobeNewswire)
Aug-03-23 01:35AM	Q2 2023 Natural Health Trends Corp Earnings Call (Thomson Reuters StreetEvents)
Aug-02-23 09:05AM	Natural Health Trends: Q2 Earnings Snapshot (Associated Press Finance)
09:00AM	Natural Health Trends Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-26-23 09:00AM	Natural Health Trends to Report Second Quarter 2023 Financial Results on August 2nd (GlobeNewswire)
Jul-12-23 06:32AM	Investors in Natural Health Trends (NASDAQ:NHTC) have unfortunately lost 62% over the last five years (Simply Wall St.)
May-04-23 12:43AM	Q1 2023 Natural Health Trends Corp Earnings Call (Thomson Reuters StreetEvents)
May-03-23 09:08AM	Natural Health Trends: Q1 Earnings Snapshot (AP Finance) -10.34%
09:00AM	Natural Health Trends Reports First Quarter 2023 Financial Results (GlobeNewswire)
Apr-26-23 09:00AM	Natural Health Trends to Report First Quarter 2023 Financial Results on May 3rd (GlobeNewswire)
Apr-21-23 10:21AM	Calculating The Intrinsic Value Of Natural Health Trends Corp. (NASDAQ:NHTC) (Simply Wall St.)
Feb-10-23 05:35AM	Natural Health Trends Full Year 2022 Earnings: EPS: US$0.028 (vs US$0.098 in FY 2021) (Simply Wall St.)
Feb-08-23 09:00AM	Natural Health Trends Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire) +10.08%
Feb-01-23 09:00AM	Natural Health Trends to Report Fourth Quarter 2022 Financial Results on February 8th (GlobeNewswire)
Jan-12-23 08:44AM	Investors Could Be Concerned With Natural Health Trends' (NASDAQ:NHTC) Returns On Capital (Simply Wall St.)
Nov-12-22 07:24AM	A Look At The Fair Value Of Natural Health Trends Corp. (NASDAQ:NHTC) (Simply Wall St.)
Nov-02-22 09:00AM	Natural Health Trends Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Oct-26-22 09:00AM	Natural Health Trends to Report Third Quarter 2022 Financial Results on November 2nd (GlobeNewswire)
Aug-22-22 08:09AM	Weak Financial Prospects Seem To Be Dragging Down Natural Health Trends Corp. (NASDAQ:NHTC) Stock (Simply Wall St.)
Aug-05-22 09:32AM	The Returns On Capital At Natural Health Trends (NASDAQ:NHTC) Don't Inspire Confidence (Simply Wall St.)
Aug-03-22 09:00AM	Natural Health Trends Reports Second Quarter 2022 Financial Results (GlobeNewswire)
Jul-27-22 09:00AM	Natural Health Trends to Report Second Quarter 2022 Financial Results on August 3rd (GlobeNewswire)
Jun-26-22 09:06AM	Investors in Natural Health Trends (NASDAQ:NHTC) have unfortunately lost 67% over the last five years (Simply Wall St.)
Jun-03-22 06:22AM	Estimating The Intrinsic Value Of Natural Health Trends Corp. (NASDAQ:NHTC) (Simply Wall St.)
May-04-22 09:00AM	Natural Health Trends Reports First Quarter 2022 Financial Results (GlobeNewswire)
Apr-27-22 09:00AM	Natural Health Trends to Report First Quarter 2022 Financial Results on May 4th (GlobeNewswire)
Mar-04-22 09:50AM	Can Mixed Financials Have A Negative Impact on Natural Health Trends Corp.'s 's (NASDAQ:NHTC) Current Price Momentum? (Simply Wall St.)
Feb-09-22 09:00AM	Natural Health Trends Reports Fourth Quarter and Full Year 2021 Financial Results (GlobeNewswire)
Feb-02-22 09:00AM	Natural Health Trends to Report Fourth Quarter and Full Year 2021 Financial Results on February 9th (GlobeNewswire)
Jan-03-22 09:14AM	Investors in Natural Health Trends (NASDAQ:NHTC) have unfortunately lost 55% over the last five years (Simply Wall St.)
Nov-03-21 09:00AM	Natural Health Trends Reports Third Quarter 2021 Financial Results (GlobeNewswire)
Oct-27-21 09:00AM	Natural Health Trends to Report Third Quarter 2021 Financial Results on November 3rd (GlobeNewswire)
Oct-01-21 09:00AM	Natural Health Trends Announces Closing of Investigation by the SEC (GlobeNewswire)
Aug-16-21 12:20PM	Natural Health Trends Corp.'s (NASDAQ:NHTC) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue? (Simply Wall St.) -10.90%
Aug-04-21 09:00AM	Natural Health Trends Reports Second Quarter 2021 Financial Results (GlobeNewswire)
Jul-28-21 09:00AM	Natural Health Trends to Report Second Quarter 2021 Financial Results on August 4th (GlobeNewswire)
May-17-21 10:24AM	Would Shareholders Who Purchased Natural Health Trends' (NASDAQ:NHTC) Stock Five Years Be Happy With The Share price Today? (Simply Wall St.)
May-05-21 09:30AM	Natural Health Trends Corp. to Host Earnings Call (ACCESSWIRE)
09:00AM	Natural Health Trends Reports First Quarter 2021 Financial Results (GlobeNewswire)
Apr-28-21 09:00AM	Natural Health Trends to Report First Quarter 2021 Financial Results on May 5th (GlobeNewswire)
Mar-17-21 07:00AM	ASECNA Continues Enhancement of the Single African Sky Using Aireon's Space-Based ADS-B as an Essential Technology (PR Newswire)

Natural Health Trends Corp. engages in the provision of direct selling and e-commerce services. It offers personal care, and wellness products through NHT Global brand. The company was founded in December, 1988 and is headquartered in Hong Kong.

Open in Screener

PRTA

Prothena Corporation plc

Feb 13 • 04:00PM ET

8.96

+0.11 1.24 %

Healthcare • Biotechnology • Ireland • NASD

PRTA Prothena Corporation plc daily Stock Chart

Peers: VRTX BIIB ALNY IONS SRPT NBIX EXEL ACAD ARWR CLDX

| Held by: XBI IWM VXF IWN IBB VTWO SCHA DFAS VHT FSCC

Index	RUT	P/E	-	EPS (ttm)	-5.21	Insider Own	19.39%	Shs Outstand	53.83M	Perf Week	0.56%
Market Cap	482.32M	Forward P/E	15.04	EPS next Y	0.60	Insider Trans	0.00%	Shs Float	43.39M	Perf Month	-2.61%
Enterprise Value	160.56M	PEG	0.61	EPS next Q	-0.56	Inst Own	89.47%	Short Float	16.28%	Perf Quarter	-17.42%
Income	-280.46M	P/S	40.91	EPS this Y	-106.80%	Inst Trans	4.14%	Short Ratio	11.94	Perf Half Y	11.17%
Sales	11.79M	P/B	1.64	EPS next Y	112.69%	ROA	-59.18%	Short Interest	7.06M	Perf YTD	-6.18%
Book/sh	5.48	P/C	1.46	EPS next 5Y	24.74%	ROE	-67.63%	52W High	16.67 -46.23%	Perf Year	-35.49%
Cash/sh	6.15	P/FCF	-	EPS past 3/5Y	- -3.15%	ROIC	-93.12%	52W Low	4.32 107.41%	Perf 3Y	-83.40%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-12.33% 178.00%	Gross Margin	69.05%	Volatility	4.49% 5.55%	Perf 5Y	-60.79%
Dividend TTM	-	EV/Sales	13.62	EPS Y/Y TTM	-112.24%	Oper. Margin	-1885.68%	ATR (14)	0.48	Perf 10Y	-71.56%
Dividend Ex-Date	-	Quick Ratio	6.61	Sales Y/Y TTM	-91.16%	Profit Margin	-2379.59%	RSI (14)	46.38	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	6.61	EPS Q/Q	38.12%	SMA20	-2.45%	Beta	-0.25	Target Price	20.33
Payout	-	Debt/Eq	0.03	Sales Q/Q	148.97%	SMA50	-5.52%	Rel Volume	0.49	Prev Close	8.85
Employees	163	LT Debt/Eq	0.02	Earnings	Nov 06 AMC	SMA200	6.62%	Avg Volume	591.84K	Price	8.96
IPO	Dec 21, 2012	Option/Short	Yes / Yes	EPS/Sales Surpr.	1.03% -63.62%	Trades		Volume	290,008	Change	1.24%

Date	Action	Analyst	Rating Change	Price Target Change
May-28-25	Downgrade	BofA Securities	Neutral → Underperform	$4
May-27-25	Downgrade	Oppenheimer	Outperform → Perform
May-27-25	Downgrade	Jefferies	Buy → Hold	$6
May-27-25	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Dec-20-24	Initiated	Chardan Capital Markets	Buy	$40
Jan-30-24	Downgrade	BofA Securities	Buy → Neutral	$68 → $38
Dec-12-23	Initiated	Deutsche Bank	Buy	$62
Apr-24-23	Initiated	SVB Securities	Outperform	$80
Jan-27-23	Initiated	Piper Sandler	Overweight	$94
Nov-04-22	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$52 → $55
Sep-28-22	Upgrade	BofA Securities	Neutral → Buy
Nov-19-21	Initiated	JMP Securities	Mkt Outperform	$77
Jun-18-21	Upgrade	BofA Securities	Underperform → Neutral	$12 → $49
Jun-08-21	Reiterated	Oppenheimer	Outperform	$45 → $54
May-26-21	Initiated	Citigroup	Buy	$39
Feb-26-21	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$14 → $28
Feb-12-21	Upgrade	Jefferies	Hold → Buy	$15 → $30
Feb-02-21	Upgrade	BTIG Research	Neutral → Buy	$29
Dec-07-20	Initiated	H.C. Wainwright	Buy	$22
Jul-09-20	Upgrade	Oppenheimer	Perform → Outperform	$16

Show Previous Ratings

Feb-16-26 09:54AM	Prothena Stock Tumbles 36.8% Year Over Year: What Lies Ahead? (Zacks)
Feb-13-26 11:40AM	FTRE vs. PRTA: Which Stock Is the Better Value Option? (Zacks)
Feb-12-26 04:05PM	Prothena to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026 (Business Wire)
Jan-21-26 12:00PM	All You Need to Know About Prothena (PRTA) Rating Upgrade to Buy (Zacks)
Jan-07-26 08:06AM	Fortrea Holdings Inc. (FTRE) Moves 5.5% Higher: Will This Strength Last? (Zacks)
04:05PM	Loading…
Dec-12-25 04:05PM	Prothena Announces Board of Directors Update (Business Wire)
Nov-19-25 04:05PM	Prothena Announces Poster Presentation on its TDP-43 CYTOPE Program at Neuroscience 2025 (Business Wire)
Nov-11-25 09:00AM	Prothena Highlights Phase 2 Data for Coramitug (Formerly PRX004) Published in Circulation, Official Journal of AHA (Business Wire)
Nov-07-25 10:32AM	Prothena Q3 Earnings Miss Estimates, Pipeline Progress in Focus (Zacks)
Nov-06-25 05:45PM	Prothena (PRTA) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:46PM	Prothena: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Prothena Reports Third Quarter 2025 Financial Results and Business Highlights (Business Wire)
Oct-30-25 04:05PM	Prothena to Report Third Quarter 2025 Financial Results on November 6 (Business Wire)
Oct-22-25 03:33PM	Prothena Corporation plc (PRTA): A Bull Case Theory (Insider Monkey)
Oct-01-25 04:45PM	Prothenas Partner Bristol Myers Squibb Obtains Fast Track Designation from the U.S. FDA for BMS-986446 (PRX005), an Anti-MTBR-Tau-Targeting Antibody, for the Treatment of Alzheimers Disease (Business Wire)
10:01AM	Loading…
Sep-11-25 10:01AM	Prothena Down 40% Year to Date: What Lies Ahead for the Stock? (Zacks)
Sep-03-25 11:30AM	Prothena (PRTA) Up 17.6% Since Last Earnings Report: Can It Continue? (Zacks)
Aug-28-25 04:05PM	Prothena to Participate in the Cantor Fitzgerald Global Healthcare Conference (Business Wire)
Aug-27-25 04:05PM	Prothena Provides Update on PRX012 and Announces Results from the Phase 1 ASCENT Clinical Program (Business Wire)
Aug-08-25 05:07AM	Elevidys sales weaken; Neumora gets into obesity (BioPharma Dive)
Aug-06-25 09:00AM	Prothena Announces that Novo Nordisk Will Advance Coramitug (Formerly PRX004) into Phase 3 Development for ATTR Amyloidosis with Cardiomyopathy (Business Wire) +12.66%
Aug-04-25 05:50PM	Prothena (PRTA) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:47PM	Prothena: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Prothena Reports Second Quarter 2025 Financial Results and Business Highlights (Business Wire)
Jul-30-25 10:01AM	PTC Therapeutics (PTCT) Surges 11.2%: Is This an Indication of Further Gains? (Zacks)
Jul-29-25 10:00AM	Earnings Preview: Rhythm Pharmaceuticals, Inc. (RYTM) Q2 Earnings Expected to Decline (Zacks)
Jul-28-25 04:05PM	Prothena to Report Second Quarter 2025 Financial Results on August 4 (Business Wire)
Jul-24-25 10:46AM	Roche Reports 7% 1H25 Sales Growth, Key Drugs Perform Well (Zacks)
Jul-17-25 01:07PM	AstraZeneca's AL Amyloidosis Drug Misses Goal in Late-Stage Studies (Zacks)
Jul-04-25 01:51PM	PRTA Dives 53.5% YTD: Will the Restructuring Effort Boost Prospects? (Zacks)
07:22AM	Loading…
Jun-20-25 07:22AM	Prothena to lay off majority of staff; Zealand shares obesity drug data (BioPharma Dive)
Jun-18-25 04:05PM	Prothena Announces Corporate Restructuring (Business Wire)
Jun-17-25 01:30PM	Roche's Phase 3 Move Boosts Outlook for Prothena Corporation plc (PRTA) (Insider Monkey)
09:16AM	Morning Movers: Sage Therapeutics surges after deal to be acquired by Supernus (TipRanks)
Jun-16-25 10:22AM	Roche, waving off study failures, commits to Phase 3 trials for Parkinsons drug (BioPharma Dive) +11.42%
09:49AM	RHHBY to Advance Parkinson's Disease Drug to Late-Stage Development (Zacks)
01:06AM	Prothenas Partner Roche to Advance Prasinezumab into Phase III Development for Early-Stage Parkinson's Disease (Business Wire)
May-29-25 03:40PM	Citizens JMP Slashes Prothena (PRTA) to $29 from $78 After AFFIRM-AL Trial Fails (Insider Monkey)
May-28-25 01:55PM	Oppenheimer Downgrades Prothena Corporation (NASDAQ:PRTA) to Perform from Outperform (Insider Monkey)
May-27-25 01:08PM	Jefferies Downgrades Prothena Corporation (PRTA) After Negative Trial Results (Insider Monkey) -30.40%
10:20AM	Prothena's Late-Stage Study for AL Amyloidosis Fails, Stock Down (Zacks)
07:53AM	Biogen strikes RNAi deal with City; Aurion withdraws IPO (BioPharma Dive)
07:43AM	Why Is Prothena Stock Trading Lower On Tuesday? (Benzinga)
May-26-25 06:16AM	Prothenas Phase III trial for AL amyloidosis treatment misses endpoint (Clinical Trials Arena)
May-23-25 04:05PM	Prothena Announces Phase 3 AFFIRM-AL Clinical Trial for Birtamimab in Patients with AL Amyloidosis Did Not Meet Primary Endpoint (Business Wire) -30.40%
May-09-25 01:28PM	Prothena Q1 Earnings Miss Estimates, Focus on Key Readouts in 2025 (Zacks)
08:29AM	Is Prothena Corporation plc (PRTA) the Low Risk High Reward Stock Set to Triple by 2030? (Insider Monkey)
May-08-25 05:50PM	Prothena (PRTA) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:47PM	Prothena: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Prothena Reports First Quarter 2025 Financial Results and Business Highlights (Business Wire)
May-07-25 12:44PM	Prothena Q1 2025 Earnings Preview (Seeking Alpha)
May-01-25 04:05PM	Prothena to Report First Quarter 2025 Financial Results on May 8 (Business Wire) -5.22%
Apr-16-25 11:49AM	Biogen & Partner Eisai Get EU Nod for Alzheimer's Drug Leqembi (Zacks)
Feb-21-25 02:15AM	Prothena Corp PLC (PRTA) Q4 2024 Earnings Call Highlights: Strong Financial Position Amidst ... (GuruFocus.com)
Feb-20-25 05:25PM	Prothena (PRTA) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:22PM	Prothena: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Prothena Reports Fourth Quarter and Full Year 2024 Financial Results, and Provides Financial Guidance and Business Highlights (Business Wire)
Feb-13-25 04:05PM	Prothena to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025 (Business Wire)
Dec-30-24 04:05PM	Prothena Announces Board of Directors Update (Business Wire) -6.92%
Dec-19-24 04:22PM	Prothena Catapults, Flashing A Bullish Sign, On Promise In Parkinson's Disease (Investor's Business Daily) +33.97%
08:09AM	Prothenas Parkinsons study fails primary endpoint despite some success (Clinical Trials Arena)
01:05AM	Roches Phase IIb Study of Prasinezumab Missed Primary Endpoint, But Suggests Possible Clinical Benefit in Early-Stage Parkinsons Disease (Business Wire)
Dec-12-24 11:30AM	Why Is Prothena (PRTA) Down 17.9% Since Last Earnings Report? (Zacks)
Nov-12-24 05:55PM	Prothena (PRTA) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:56PM	Prothena: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Prothena Reports Third Quarter 2024 Financial Results and Business Highlights (Business Wire)
Nov-05-24 04:05PM	Prothena to Report Third Quarter 2024 Financial Results on November 12 (Business Wire) +8.71%
Oct-29-24 12:00PM	Prothena (PRTA) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
04:48AM	Strength Seen in Prothena (PRTA): Can Its 15.0% Jump Turn into More Strength? (Zacks)
Oct-18-24 03:01PM	State Street Corp's Strategic Reduction in Prothena Corp PLC Holdings (GuruFocus.com)
Sep-27-24 04:05PM	Prothena Announces Leadership Team Updates (Business Wire) -16.56%
Aug-29-24 04:05PM	Prothena to Participate in Upcoming Healthcare Conferences (Business Wire)
Aug-19-24 12:00PM	What Makes Prothena (PRTA) a New Buy Stock (Zacks)
Aug-18-24 12:28AM	Prothena Corporation plc (PTRA): Positioning Among Top Debt-Free Stocks (Insider Monkey)
Aug-17-24 08:22AM	7 Best Debt Free Stocks To Buy (Insider Monkey)
Aug-09-24 09:16AM	Prothena (PRTA) Q2 Earnings Benefit From Collaboration Revenues (Zacks)
Aug-08-24 06:40PM	Prothena (PRTA) Q2 Earnings and Revenues Beat Estimates (Zacks)
05:33PM	Prothena: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Prothena Reports Second Quarter 2024 Financial Results and Business Highlights (Business Wire)
Aug-01-24 04:05PM	Prothena to Report Second Quarter 2024 Financial Results on August 8 (Business Wire) -5.20%
Jul-25-24 10:02AM	Prothena (PRTA) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release (Zacks)
Jun-24-24 08:48AM	Prothena (PRTA) Moves 9.3% Higher: Will This Strength Last? (Zacks)
Jun-11-24 04:07PM	Eli Lilly Seesaws On FDA Win, And Pushes Alzheimer's Stocks Prothena, Eisai Lower (Investor's Business Daily)
12:20PM	Eli Lilly Drags Alzheimer's Stocks Prothena, Eisai Lower Despite FDA Win (Investor's Business Daily)
Jun-07-24 11:30AM	Why Is Prothena (PRTA) Down 1.5% Since Last Earnings Report? (Zacks)
May-29-24 10:26AM	Prothena (PRTA), Bristol Myers Tie Up for Second Neuro Candidate (Zacks)
08:46AM	BMS stakes $80m on Prothenas neurodegenerative candidate (Pharmaceutical Technology)
May-28-24 04:05PM	Prothena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration (Business Wire)
May-09-24 11:52AM	Prothena (PRTA) Q1 Earnings Miss Estimates on Higher R&D Expenses (Zacks)
May-08-24 10:56PM	PRTA Stock Earnings: Prothena Corp Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
06:10PM	Prothena (PRTA) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
05:14PM	Prothena: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Prothena Reports First Quarter 2024 Financial Results and Business Highlights (Business Wire)
May-01-24 04:05PM	Prothena to Report First Quarter 2024 Financial Results on May 8 (Business Wire) +5.31%
Apr-25-24 10:01AM	Earnings Preview: Prothena (PRTA) Q1 Earnings Expected to Decline (Zacks)
Apr-15-24 04:05PM	Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma (Business Wire)
Mar-28-24 08:00AM	Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback (Investor's Business Daily)
Mar-05-24 04:05PM	Prothena to Participate in Upcoming Healthcare Conferences (Business Wire)
Mar-04-24 04:05PM	Prothena Appoints David Ford to Newly Created Chief People Officer Position (Business Wire)
Feb-21-24 04:05PM	Prothena Announces Appointment of Daniel G. Welch as Director and Chair Designate (Business Wire)

Prothena Corp. Plc is a clinical-stage neuroscience company, which engages in the discovery and development of novel therapies to change the course of devastating diseases. The firm's clinical pipeline includes both wholly owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
EcoR1 Capital, LLC	10% Owner	May 02 '25	Sale	8.36	3,317,938	27,744,929	8,266,342	May 06 07:06 PM
EcoR1 Capital, LLC	10% Owner	May 06 '25	Sale	7.64	1,984,053	15,164,712	5,304,596	May 06 07:06 PM
EcoR1 Capital, LLC	10% Owner	May 05 '25	Sale	8.11	977,693	7,930,166	7,288,649	May 06 07:06 PM

NHTC

Natural Health Trends Corp

PRTA

Prothena Corporation plc

Upgrade your FINVIZ experience